Aquinox Pharma appoints two executives
Ms. Jenkins has amassed nearly 20 years of commercial leadership experience spanning start-up Biotech enterprises to large Pharmaceutical companies. She specializes in launching brands into markets with high unmet clinical needs and brings expertise leading strategic marketing, sales, and market access functions.
Most recently Mrs. Jenkins served as Vice-President, Market Access at Relypsa. She previously served as Vice President, Business Development at Actavis, (now Allergan plc) as well as Senior Director of Marketing at MedImmune. She also brings eight years of senior marketing and sales experience with Pfizer Inc.
Mr. Brennan brings more than 25 years of experience in building and leading pharmaceutical and biotechnology companies in the United States, Europe and Canada with a strong track-record in partnering and licensing transactions.
Previously, Mr. Brennan was Senior Vice-President of Business Development at Arbutus Biopharma Corp. (formerly Tekmira Pharmaceuticals Corp.) prior to which he served as CEO of Altair Therapeutics.
He also served in senior business development and regulatory affairs roles with AstraZeneca PLC, operating in Sweden, the United Kingdom and Canada. ■
LATEST MOVES FROM British Columbia
- Lithium Americas appoints two directors
- Archer Petroleum appoints new CEO and CFO
- Napier Ventures director and CFO Michael Raftery resigns
- Group Ten Metals appoints Tim Thiessen as CFO
- Cardiome Pharma appoints Justin Renz as CFO
More inside POST
CEO, choose your inner circle carefully Leadership